Compare Adobe Systems Inc (ADBE) vs Davita Inc (DVA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adobe Systems Inc vs Davita Inc — how do they compare? Adobe Systems Inc trades at $220.64 (market cap $88.06B), while Davita Inc trades at $231.35 (market cap $15.04B). The key difference: Adobe Systems Inc is far larger — about 5.9× Davita Inc's market cap, and Davita Inc is trading nearer its 52-week high, Adobe Systems Inc nearer its low. Which is the better fit depends on your goals.
| ADBE | DVA | |
|---|---|---|
Market Cap | $88.06B | $15.04B |
Volume | 5,187,646 | — |
Sector | Technology | Health |
52-Week High | $382.24 | $235.71 |
52-Week Low | $193.41 | $103.87 |
Enterprise Value | $89.50B | $27.59B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Adobe Inc. (ADBE) trades at $220.94, up 1.32% with strong fundamentals including 29.99% net margin and consistent earnings beats. Technical indicators show bullish momentum with support at $218 and resistance at $228. Recent news highlights institutional buying despite AI competition concerns, while cash flow remains robust at $10.03B from operations in 2025.
Outlook remains positive with a $246.75 analyst target, though risks include AI disruption and CEO transition. Valuation appears attractive with P/E of 12.67, supporting a buy case for long-term growth investors amid near-term volatility.
DaVita (DVA) trades at $234.31, showing modest daily decline but maintaining strong momentum near 52-week highs. The stock exhibits bullish technical signals with positive moving averages, though RSI levels suggest potential overbought conditions. Fundamentally, revenue growth continues with $13.64B in 2025, while net margins of 5.65% reflect steady profitability. Recent news highlights DVA's expansion in kidney care delivery and AI-driven scheduling improvements, positioning the company for continued growth in specialized healthcare services.
Investment outlook remains positive with analyst consensus favoring Buy ratings (39%) and price targets averaging $211. Key opportunities include expanding kidney care services and operational efficiencies, while risks involve high debt levels (65.55% debt-to-asset ratio) and healthcare regulatory pressures. Current valuation metrics (P/E 22.71, P/S 1.24) appear reasonable given growth prospects, though the stock trades above consensus targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adobe Systems Inc
Adobe Inc. develops, markets, and supports computer software products and technologies. The Company's products allow users to express and use information across all print and electronic media. Adobe offers a line of application software products, type products, and content for creating, distributing, and managing information.
Read more on ADBE →About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →
